Names & Terms You Will Hear
Plain-language meanings for the terms your care team may use.
| Term | Meaning |
|---|---|
| Aspirin | ASA (acetylsalicylic acid) |
| Baby aspirin | Low-dose aspirin — 81 mg/day |
| Primary prevention | Aspirin to prevent a FIRST heart event |
| Secondary prevention | Aspirin after a heart attack, stent, or stroke |
| Antiplatelet therapy | Medicine that prevents blood clots |
| DAPT | Dual antiplatelet therapy — aspirin + a second drug |
| Clopidogrel / Plavix | Common second antiplatelet drug used with aspirin |
| ASCVD | Atherosclerotic cardiovascular disease — artery-clogging |
| 10-year ASCVD risk | Your estimated chance of a heart attack in 10 years |
| USPSTF | U.S. Preventive Services Task Force — sets prevention grades |
| GI bleed | Bleeding in the stomach or intestines |
| Enteric-coated aspirin | Aspirin with a coating to delay dissolving in the stomach |
What Is Aspirin for Prevention?
- Aspirin is a medicine that reduces clotting. It makes blood platelets less sticky. This lowers the chance of a clot blocking an artery.
- If you already had a heart attack, stroke, or stent: aspirin prevents a second event. This is called secondary prevention.
- If you have NOT had a heart attack or stroke: aspirin might prevent a first event. But the benefit is smaller. The bleed risk is real.
- The rules changed in 2022. Large trials showed that aspirin causes more harm than good in healthy adults over 60.
- The USPSTF (U.S. Preventive Services Task Force) rates aspirin by age. Grade B: ages 50–59 with high risk. Grade C: ages 40–49. Grade D (against): ages 60 and older.
Why It Matters
- Many patients took aspirin for years based on old advice. Three major trials in 2018 changed the picture.
- ASPREE (2018): Healthy adults age 70+ took aspirin or a placebo. Aspirin did not prevent heart attacks. It raised the risk of serious bleeding.
- ASCEND (2018): In people with diabetes, aspirin gave a small benefit. That benefit was offset by more bleeding. Net result: a wash.
- ARRIVE (2018): In moderate-risk adults, aspirin had no clear effect.
- If you had a heart attack, stroke, stent, or bypass: aspirin IS standard care. Do not stop it without asking your doctor.
- Stopping aspirin after a stent can cause a clot in the stent. That clot can cause a fatal heart attack. This is a medical emergency.
Key Clinical Trials That Changed Practice
| Trial (Year) | Who Was Studied | Main Finding | Takeaway |
|---|---|---|---|
| ASPREE (2018) | Healthy adults ≥70 in Australia/US | Aspirin did not prevent CV events; raised bleeds and death | Do not start aspirin at age 70+ for primary prevention |
| ASCEND (2018) | Adults with diabetes, no known CVD | Marginal CV benefit offset by major bleeds — net neutral | Shared decision only; routine use not recommended |
| ARRIVE (2018) | Moderate-risk adults, no diabetes/CVD | No significant CV event reduction | Primary prevention aspirin did not help this group |
| DAPT (2014) | Patients after coronary stent placement | Extended DAPT (30 months) reduced stent clots and MI | After a stent, DAPT for 12+ months reduces serious events |
Risk Factors
Knowing your personal risks helps your care team take extra precautions.
| Risk Factor | Why It Increases Risk |
|---|---|
| Age 60 or older | Older blood vessels are more fragile. Bleed risk rises with age. |
| Prior stomach ulcer or GI bleed | Aspirin irritates the stomach. A past GI bleed raises future bleed risk. |
| NSAIDs (ibuprofen, naproxen) | Aspirin plus NSAIDs sharply raises GI bleed risk. |
| H. pylori infection | This stomach bacteria combined with aspirin raises bleed risk. |
| Uncontrolled high blood pressure | High BP raises the risk of bleeding in the brain. |
| Heavy alcohol use | Alcohol irritates the stomach and raises bleed risk. |
| Blood thinners (warfarin, Eliquis, Xarelto) | Adding aspirin to a blood thinner raises bleed risk a lot. |
| Chronic kidney disease | The kidneys clear aspirin slowly. Bleed risk is higher. |
Primary Prevention — Ages 40 to 49 (USPSTF Grade C)
- Grade C means: uncertain benefit. Aspirin may help some people in this age group — but not most.
- Consider aspirin ONLY if your 10-year heart risk is 10% or higher AND you have no increased bleed risk.
- You must value the chance of preventing a heart attack more than the risk of a serious bleed. That is your call to make with your doctor.
- Use the ACC PREVENT calculator (tools.acc.org) to check your 10-year risk. Discuss the result before deciding.
- This is a close call. Have a shared decision talk before starting.
Primary Prevention — Ages 50 to 59 (USPSTF Grade B)
- Grade B means: there is moderate benefit for some patients at this age.
- Aspirin is an option IF your 10-year heart risk is 10% or higher AND you do not have a high risk of bleeding.
- You must also be willing to take aspirin every day for many years.
- Not sure of your risk? Ask your doctor to check it at your next visit.
- If you start aspirin at this age, do not keep taking it forever without review. Reassess each year with your doctor.
Primary Prevention — Ages 60 and Older (USPSTF Grade D)
- Grade D means: the USPSTF recommends AGAINST starting aspirin for primary prevention at age 60 or older.
- ASPREE trial (2018): 19,114 healthy adults aged 70+. Aspirin did not prevent heart attacks. It raised the risk of serious bleeding and death.
- If you are taking aspirin for primary prevention and you are now 60 or older, talk to your doctor. You may be able to safely stop.
- Stopping primary-prevention aspirin is DIFFERENT from stopping aspirin after a stent or heart attack. Ask your doctor which applies to you.
- Do not stop aspirin on your own if you have a stent. That is dangerous.
Treatment Options
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
- Standard dose: 81 mg once daily (baby aspirin). It gives the same heart protection as 325 mg.
- 325 mg (regular aspirin) does NOT add more heart protection. It does cause more stomach bleeding. Always choose 81 mg.
- Enteric-coated aspirin has a special coating. It does NOT reliably prevent stomach bleeding. The coating delays dissolving but does not protect the gut.
- Take aspirin with food to reduce stomach upset.
- DAPT (dual antiplatelet therapy): After a stent or heart attack, your doctor will add a second drug. Options: clopidogrel (Plavix), ticagrelor (Brilinta), or prasugrel (Effient). DAPT lasts 1 to 12 months based on your risk.
- Do NOT stop aspirin if you have a stent or history of heart attack. Call your cardiologist first.
Special Populations:
• Diabetes: ASCEND trial showed marginal benefit offset by bleeds. Not routine. Discuss with your doctor.
• Pregnancy: 81 mg IS recommended for women at high risk of pre-eclampsia. Start at 12 to 28 weeks. Ask your OB or midwife.
• Colon cancer: Research suggests aspirin may lower colon cancer risk. The FDA has not approved this use. Discuss with your doctor.
• Post-bypass / post-TAVR: Your surgeon sets the exact regimen. Follow their instructions.
• Diabetes: ASCEND trial showed marginal benefit offset by bleeds. Not routine. Discuss with your doctor.
• Pregnancy: 81 mg IS recommended for women at high risk of pre-eclampsia. Start at 12 to 28 weeks. Ask your OB or midwife.
• Colon cancer: Research suggests aspirin may lower colon cancer risk. The FDA has not approved this use. Discuss with your doctor.
• Post-bypass / post-TAVR: Your surgeon sets the exact regimen. Follow their instructions.
Risks, Benefits, and Alternatives
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.
| Option | Risks | Benefits | Alternatives |
|---|---|---|---|
| Aspirin — primary prevention (age 40–59, ASCVD ≥10%) | GI bleed ~1–3%/year. Brain bleed risk rises with age. | May cut first heart attack ~10% in high-risk adults age 50–59. | Diet, exercise, no smoking. Statin if LDL is high. BP control. |
| Aspirin — secondary prevention (prior MI, stroke, stent, PAD, bypass) | GI bleed ~1–2%/year. Higher if on blood thinner. Do not stop abruptly after stent. | Cuts second heart attack ~20–25%. Reduces stent clots. Reduces stroke after TIA. | Clopidogrel (Plavix) if aspirin not tolerated. Ticagrelor for ACS. |
| DAPT (aspirin + second drug) after stent or heart attack | Higher bleed risk than aspirin alone. Major bleed ~2–3%/year. Do not stop early. | Prevents clot in stent. Reduces second MI by 30–40% in first year. | High bleed risk: shorten DAPT duration. Add a PPI to protect the stomach. |
| No aspirin (primary prevention, age 60+) | No bleed risk. No drug interactions. | Avoids harm shown in ASPREE trial. Right choice for most adults 60+. | Control BP, LDL, blood sugar, weight. Stop smoking. Consider statin. |
Common Misconceptions
| Myth | Reality |
|---|---|
| More aspirin = more protection | FALSE. 81 mg protects the heart as well as 325 mg. Higher doses only raise the risk of stomach bleeding. |
| Enteric-coated aspirin protects the stomach | FALSE. The coating delays dissolving. Aspirin still reaches the stomach lining. Bleeding can still happen. The coating does not protect you. |
| I took aspirin 20 years — stopping is dangerous | It depends on WHY you take it. Primary prevention only (no stent or MI): you can likely stop with your doctor. After a stent or heart attack: stopping abruptly IS dangerous. Ask your cardiologist first. |
| My doctor ordered it years ago, so I keep taking it | Guidelines changed in 2022. Ask your doctor to review it at your next visit — especially if you are now over 60. |
| Aspirin is a blood thinner like warfarin or Eliquis | Not exactly. Aspirin stops platelets from clumping. That is different from true blood thinners. But aspirin plus a blood thinner raises bleed risk. Always tell every doctor all the medicines you take. |
| Aspirin prevents all strokes | Aspirin helps prevent clot-caused strokes. It does NOT protect against bleeding strokes. In fact, aspirin can make a bleeding stroke worse. |
Possible Complications
Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.
| Where / What | What Can Happen |
|---|---|
| Stomach / gut | GI bleeding: blood in stool, dark or tarry stool, stomach pain. Risk ~1–3%/year. Higher with 325 mg, NSAIDs, H. pylori, or a past ulcer. |
| Brain | Brain bleed (hemorrhagic stroke): rare but serious. Risk rises with high blood pressure and older age. |
| Stomach lining | Stomach ulcer: aspirin blocks an enzyme that protects the stomach. A PPI (like omeprazole) can reduce this risk. |
| After a stent | Stent clot: stopping aspirin can cause a clot in the stent. This can cause a fatal heart attack. Never stop on your own. |
| Drug interactions | Ibuprofen (Advil) blocks aspirin's effect when taken first. Take aspirin 30 minutes before ibuprofen, or use acetaminophen. |
| Aspirin allergy | True allergy (rare): hives, trouble breathing. AERD: aspirin can worsen asthma in some people. Tell your doctor if aspirin causes any reaction. |
Points to Know
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you remember nothing else, remember these key points.
- The rules changed in 2022. Adults 60 and older should NOT start aspirin for primary prevention. The ASPREE trial showed more harm than benefit.
- If you had a heart attack, stroke, stent, or bypass: keep taking aspirin. Do not stop without calling your cardiologist.
- 81 mg is the right dose. 325 mg adds no extra heart protection. It only causes more stomach bleeding.
- Enteric-coated aspirin does NOT reliably prevent GI bleeds. The coating delays, but does not prevent, stomach irritation.
- Tell every doctor you take aspirin. It interacts with ibuprofen and blood thinners.
- If you have a stent and need surgery, your surgeon MUST know you take aspirin. Never stop DAPT without your cardiologist's approval.
- Aspirin is recommended in pregnancy for women at high risk of pre-eclampsia — starting as early as 12 weeks. Ask your OB/midwife.
When to Call Us — and When to Call 911
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you are not sure, call. We would rather hear from you twice than miss a real problem.
- Call 911: chest pain, jaw pain, trouble breathing, sudden severe headache, face drooping, arm weakness, or slurred speech. These are heart attack or stroke signs.
- Call 911: black or tarry stools, bloody stools, or vomiting blood. These are signs of serious stomach bleeding.
- Call our office: you want to stop aspirin but have a stent or history of heart attack. Do NOT stop on your own.
- Call our office: you are not sure if you should start or stop aspirin based on your age and health history.
- Call our office: you started a new medicine — ibuprofen, naproxen, warfarin, Eliquis, or Xarelto — and you also take aspirin.
- Call our office: you are pregnant and want to know if aspirin is right for you to prevent pre-eclampsia.
- Call our office: unusual bruising, bleeding that will not stop, or blood in your urine.
Office: (727) 943-5200
Trusted Resources
Independent, evidence-based pages we recommend for deeper reading.
- USPSTF — Aspirin for Primary Prevention (Official 2022 Recommendation) — The official, evidence-graded recommendation on aspirin for primary prevention.
- AHA / Heart.org — Aspirin and Heart Disease — Patient-friendly AHA overview of aspirin's role in heart disease.
- Cleveland Clinic — Aspirin for Heart Attack and Stroke — Straightforward Cleveland Clinic patient guide on aspirin, dosing, and when to use it.
- Mayo Clinic — Daily Aspirin Therapy — Mayo Clinic's explanation of who benefits from daily aspirin and the risks involved.
- ACC PREVENT / ASCVD Risk Estimator — Free online tool to estimate your 10-year heart attack risk — used to guide aspirin decisions.
- CAD Patient Guide — go.riasalimd.com/cad-guide — Companion guide on coronary artery disease — why aspirin matters in secondary prevention.
- ACS / Heart Attack Guide — go.riasalimd.com/acs-guide — Companion guide on heart attacks — includes DAPT and aspirin after a heart attack.
Sources Used to Build This Guide
- USPSTF 2022 — Aspirin Use to Prevent Cardiovascular Disease (Final Recommendation) [guideline] — Primary source for age-stratified primary prevention recommendations (Grades B, C, D) and the 2022 paradigm shift.
- ASPREE Trial (McNeil et al., 2018) — NEJM: Aspirin in Healthy Elderly [clinical_trial] — Key trial showing no net cardiovascular benefit and increased bleeding/mortality in healthy adults ≥70; foundation for Grade D recommendation for ages 60+.
- ASCEND Trial (ASCEND Study Collaborative Group, 2018) — NEJM: Aspirin in Diabetes [clinical_trial] — Showed marginal cardiovascular benefit offset by increased major bleeding in diabetics without established CVD; informs shared decision-making for diabetic patients.
- ARRIVE Trial (Gaziano et al., 2018) — Lancet: Aspirin in Moderate-Risk Patients [clinical_trial] — Showed aspirin did not reduce cardiovascular events in moderate-risk adults without diabetes; supports selective use in primary prevention.
- ACC/AHA 2019 Guideline on the Primary Prevention of Cardiovascular Disease [guideline] — AHA/ACC professional society recommendation that low-dose aspirin be considered (Class IIb) only for selected high-risk 40–70-year-olds for primary prevention; not recommended for ≥70.
- DAPT Trial (Mauri et al., 2014) — NEJM: Dual Antiplatelet Therapy after Stenting [clinical_trial] — Defined optimal duration of dual antiplatelet therapy (DAPT) post-stent; foundational evidence for secondary prevention DAPT duration recommendations.
- AHA/ACC 2022 Aspirin Update Statement [guideline] — Updated 2022 ACC/AHA commentary aligning with USPSTF on reduced role of aspirin in primary prevention for adults ≥60 and reinforcing secondary prevention recommendations.
- Cleveland Clinic — Aspirin and Heart Disease [patient_resource] — Plain-language patient-facing overview of aspirin use in heart disease; used for tone calibration and cross-referencing lay-language explanations.
- Mayo Clinic — Daily Aspirin Therapy [patient_resource] — High-quality patient-facing resource for daily aspirin therapy, dosing, and who should consider it; used for readability benchmarking.
- AHA Patient Pages — Aspirin and Heart Disease [patient_resource] — AHA patient-facing content on aspirin for heart attack and heart disease; ensures alignment with recognized patient education standards.
- ACC PREVENT Pooled Cohort Equations / 10-Year ASCVD Risk Calculator [clinical_tool] — 10-year ASCVD risk estimation tool referenced for determining eligibility threshold (≥10%) for primary prevention aspirin consideration.
- Burn et al. (2011) — Lancet Oncology: Aspirin and Colorectal Cancer Prevention [research_article] — Evidence that aspirin reduces colorectal cancer (CRC) risk; noted in special populations section with the caveat that FDA has not approved this indication.
- ACOG Practice Bulletin — Low-Dose Aspirin in Pregnancy for Pre-eclampsia Prevention [guideline] — Supports the positive indication for low-dose aspirin (81 mg) in high-risk pregnancies starting 12–28 weeks to reduce pre-eclampsia risk.
